Structure Therapeutics (GPCR) Equity Ratio (2022 - 2026)
Quarterly Equity Ratio rose 0.83% to 0.96 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.96 through Mar 2026, up 0.83% year-over-year, with the annual reading at 0.96 for FY2025, 0.0% changed from the prior year.
Structure Therapeutics' Equity Ratio history spans 5 years, with the latest figure at 0.96 for Q1 2026.
- Equity Ratio came in at 0.96 for Q1 2026, roughly flat from 0.96 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.97 in Q2 2024 to a low of 1.18 in Q4 2022.
- The 5-year median for Equity Ratio is 0.95 (2025), against an average of 0.79.
- Year-over-year, Equity Ratio surged 179.86% in 2023 and then decreased 3.71% in 2025.
- Structure Therapeutics' Equity Ratio stood at 1.18 in 2022, then soared by 179.86% to 0.94 in 2023, then increased by 1.88% to 0.96 in 2024, then decreased by 0.0% to 0.96 in 2025, then grew by 0.23% to 0.96 in 2026.
- Per Business Quant, the three most recent readings for GPCR's Equity Ratio are 0.96 (Q1 2026), 0.96 (Q4 2025), and 0.93 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.21 |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 0.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.96 |
| Dec 31, 2025 | 0.96 |
| Sep 30, 2025 | 0.93 |
| Jun 30, 2025 | 0.95 |
| Mar 31, 2025 | 0.95 |
| Dec 31, 2024 | 0.96 |
| Sep 30, 2024 | 0.96 |
| Jun 30, 2024 | 0.97 |
| Mar 31, 2024 | 0.94 |
| Dec 31, 2023 | 0.94 |
| Sep 30, 2023 | 0.89 |
| Jun 30, 2023 | 0.93 |
| Mar 31, 2023 | 0.96 |
| Dec 31, 2022 | -1.18 |